Abstract

http://ssrn.com/abstract=1907401
 


 



Commercial Speech, Drugs, Promotion and a Tailored Television Advertisement Moratorium


Margaret Gilhooley


Seton Hall University - School of Law

August 9, 2011

Health Matrix: Journal of Law-Medicine, Vol. 21, 2011

Abstract:     
The commercial speech doctrine has already had a major impact on drug regulation. This article examines the justification in two areas for limiting the information that drug companies provide to consumers or doctors about drugs with a high risk potential. The paper will first discuss the constitutionality of a tailored safety moratorium on television advertisements for drugs with a high risk potential. The article will then examine the constitutionality of imposing limitations on the ability of a drug manufacturer to initiate giving or mailing to doctors reprints of medical journal articles that discuss new but unapproved uses for drugs. The Obama Administration objects only to "promotional" distributions under a narrow test. While the constitutionality of restrictions is a contentious issue, this paper maintains that the safety risks to the public rightly deserve great weight under the commercial speech doctrine.

Number of Pages in PDF File: 13

Accepted Paper Series


Download This Paper

Date posted: August 10, 2011  

Suggested Citation

Gilhooley, Margaret, Commercial Speech, Drugs, Promotion and a Tailored Television Advertisement Moratorium (August 9, 2011). Health Matrix: Journal of Law-Medicine, Vol. 21, 2011. Available at SSRN: http://ssrn.com/abstract=1907401

Contact Information

Margaret Gilhooley (Contact Author)
Seton Hall University - School of Law ( email )
One Newark Center
Newark, NJ 07102-5210
United States
Feedback to SSRN


Paper statistics
Abstract Views: 467
Downloads: 24

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo8 in 0.297 seconds